Article

Generic Severe Chronic Pain Treatment Launched

Author(s):

Generic tramadol hydrochloride extended-release tablets treat moderate to moderately severe chronic pain.

Mylan is launching tramadol hydrochloride extended-release tablets—a generic version of Valeant’s Ultram extended-release tablets.

The FDA approved Mylan’s abbreviated new drug application for the product, which can be used to treat moderate to moderately severe chronic pain in adults who need around-the-clock pain treatment for an extended period of time.

Mylan also has 265 abbreviated new drug applications pending FDA approval.

Tramadol hydrochloride extended-release tablets USP, 100 mg, 200 mg, and 300 mg, brought in US sales of around $52.8 million in 2015, according to IMS Health.

Aurobindo Pharma Limited also announced back in October 2015 that it had received final approval from the FDA to manufacture and market a generic version of Ultram.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Asthma COPD Breath Nebulizer And Mask Given By Doctor Or Nurse - Image credit: Angelov | stock.adobe.com
1 expert in this video
1 expert in this video
1 expert in this video
Psychiatric pharmacist and patient -- Image credit: NanSan | stock.adobe.com